Evaluation of a Telehealth DPP With Medicare Patients at the University of Mississippi Medical Center

Active, not recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions
PreDiabetesPrediabetic State
Interventions
BEHAVIORAL

Diabetes Prevention Program (DPP)

Individuals with prediabetes can mitigate the risks and costs of diabetes by taking preventative action, such as participation in a National Diabetes Prevention Program (DPP). The DPP began as a multisite randomized controlled trial demonstrating the effectiveness and cost-benefit of a 12-month intensive lifestyle intervention over pharmaceutical treatment for preventing or delaying diabetes among prediabetic participants. In 2010, Congress authorized the Centers for Disease Control and Prevention to lead the dissemination of the DPP as a targeted approach (high risk populations) and population-based strategy to reduce the incidence of diabetes and diabetes-related healthcare costs. The goal is to achieve modest weight loss (7%) by developing and implementing behavior change skills resulting in lifestyle modifications such as physical activity (150 minutes per week) and dietary and nutritional practices.

Trial Locations (1)

39216

University of Mississippi Medical Center, Jackson

All Listed Sponsors
collaborator

American Medical Association

OTHER

collaborator

Mississippi State Department of Health

OTHER_GOV

lead

University of Mississippi Medical Center

OTHER